Schrodinger, Inc.

SDGR

$11.08

Name : Schrodinger, Inc.

Sector : Healthcare

Industry: Health Information Services

Mark. Cap: $817,982,144.00

EPSttm : -1.41

Schrodinger, Inc.

$11.08

4.24%

$0.49

SDGR — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

18.01

Margin Of Safety %

-15

Put/Call OI Ratio

0.63

EPS Next Q Diff

-1.1

EPS Last/This Y

-0.73

EPS This/Next Y

0.7

Price

11.07

Target Price

23.11

Analyst Recom

1.44

Performance Q

-39.72

Upside

-545.4%

Beta

1.6

Ticker: SDGR

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	SDGR	12.13	0.48	0.03	30808
2026-03-03	SDGR	12.51	0.47	0.07	31246
2026-03-04	SDGR	13.11	0.46	0.02	31800
2026-03-05	SDGR	13.03	0.46	0.15	32055
2026-03-06	SDGR	12.74	0.46	0.10	32159
2026-03-09	SDGR	12.97	0.46	0.29	32189
2026-03-10	SDGR	12.63	0.46	0.12	31793
2026-03-11	SDGR	12.73	0.46	0.70	31823
2026-03-12	SDGR	12.16	0.46	0.06	31856
2026-03-13	SDGR	12.16	0.46	0.06	31856
2026-03-17	SDGR	12.3	0.46	0.86	32156
2026-03-18	SDGR	11.96	0.45	0.08	32231
2026-03-19	SDGR	12.2	0.45	0.71	32446
2026-03-20	SDGR	12.01	0.45	0.14	32428
2026-03-23	SDGR	11.87	0.69	0.04	15269
2026-03-24	SDGR	11.57	0.64	0.09	15906
2026-03-25	SDGR	11.4	0.64	0.10	16039
2026-03-26	SDGR	11.56	0.63	1.75	16250
2026-03-27	SDGR	11.07	0.63	0.04	16333
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	SDGR	12.14	14.1	-	-2.14
2026-03-03	SDGR	12.51	14.1	-	-2.14
2026-03-04	SDGR	13.12	14.1	-	-2.14
2026-03-05	SDGR	13.03	14.1	-	-2.14
2026-03-06	SDGR	12.73	14.1	-	-2.14
2026-03-09	SDGR	12.95	14.1	-	-2.14
2026-03-10	SDGR	12.64	14.1	-	-2.14
2026-03-11	SDGR	12.72	14.1	-	-2.14
2026-03-12	SDGR	12.16	14.1	-	-2.14
2026-03-13	SDGR	12.53	14.1	-	-2.14
2026-03-17	SDGR	12.30	14.1	-	-2.14
2026-03-18	SDGR	11.98	14.1	-	-2.14
2026-03-19	SDGR	12.21	14.1	-	-2.14
2026-03-20	SDGR	12.02	14.1	-	-2.14
2026-03-23	SDGR	11.87	14.1	-	-2.14
2026-03-24	SDGR	11.59	14.1	-	-2.14
2026-03-25	SDGR	11.40	14.1	-	-2.14
2026-03-26	SDGR	11.57	14.1	-	-2.14
2026-03-27	SDGR	11.07	14.1	-	-2.14
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	SDGR	-0.05	0.98	17.03
2026-03-03	SDGR	-0.05	0.98	17.03
2026-03-04	SDGR	-0.05	0.98	17.03
2026-03-05	SDGR	-0.05	0.98	17.03
2026-03-06	SDGR	-0.05	0.98	17.03
2026-03-09	SDGR	-0.15	0.97	17.03
2026-03-10	SDGR	-0.15	0.97	17.03
2026-03-11	SDGR	-0.15	0.97	17.61
2026-03-12	SDGR	-0.15	0.97	17.61
2026-03-13	SDGR	-0.15	0.97	17.61
2026-03-17	SDGR	-0.15	0.93	17.61
2026-03-18	SDGR	-0.15	0.93	17.61
2026-03-19	SDGR	-0.15	0.93	17.61
2026-03-20	SDGR	-0.15	0.93	17.61
2026-03-23	SDGR	-0.15	0.92	17.61
2026-03-24	SDGR	-0.15	0.92	17.61
2026-03-25	SDGR	-0.15	0.92	18.01
2026-03-26	SDGR	-0.15	0.92	18.01
2026-03-27	SDGR	-0.15	0.92	18.01
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.44

Avg. EPS Est. Current Quarter

-0.55

Avg. EPS Est. Next Quarter

-0.66

Insider Transactions

-0.15

Institutional Transactions

0.92

Beta

1.6

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

9.46

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

86.4

Max Drawdown 5-Year %

-85.8

Target Price

23.11

P/E

Forward P/E

PEG

P/S

3.2

P/B

2.24

P/Free Cash Flow

65.65

EPS

-1.41

Average EPS Est. Cur. Y

-2.14

EPS Next Y. (Est.)

-1.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-40.36

Relative Volume

0.74

Return on Equity vs Sector %

-55.7

Return on Equity vs Industry %

-37.6

EPS 1 7Days Diff

-0.9

EPS 1 30Days Diff

-0.91

EBIT Estimation

◆ SDGR Healthcare

$11.08

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

13/25

Volume

9/15

Valuation

12/20

TP/AR

2/10

Options

5/10

RSI

34.6

Range 1M

4.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

17/30

Estimates

1/20

Inst/Vol

3/15

Options

7/10

EPS Yr

-50.4%

EPS NY

30.3%

52W%

0.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +34.7% upside

Quality

5/30

Valuation

10/30

Growth

12/25

Stability

8/10

LT Trend

4/5

Upside

+34.7%

Quality

MoS

-15%

Schrodinger, Inc.

Sector: Healthcare

Industry: Health Information Services

Employees: 850

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

SDGR

Latest News

—

Caricamento notizie per SDGR…

stock quote shares SDGR – Schrodinger, Inc. Stock Price stock today

news today SDGR – Schrodinger, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch SDGR – Schrodinger, Inc. yahoo finance google finance

stock history SDGR – Schrodinger, Inc. invest stock market

stock prices SDGR premarket after hours

ticker SDGR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SDGR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y